Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory ReceptorsNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$741,276FederalNih-reporter · indexed 6 hours agoShare
Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative AfricansNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$560,928FederalNih-reporter · indexed 6 hours agoShare
The Southeastern HIV Implementation Science Hub: Supporting the sustained implementation of evidence-based care among academic, community, and clinical partnersNewclinicalGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionTNResponse due—Value$817,946FederalNih-reporter · indexed 6 hours agoShare
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory ReceptorsNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$741,276FederalNih-reporter · indexed 6 hours agoShare
Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative AfricansNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$560,928FederalNih-reporter · indexed 6 hours agoShare
The Southeastern HIV Implementation Science Hub: Supporting the sustained implementation of evidence-based care among academic, community, and clinical partnersNewclinicalGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionTNResponse due—Value$817,946FederalNih-reporter · indexed 6 hours agoShare
Project 1: Rational design of targeted vaccines to induce HIV V2-apex bnAb responsesNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$1,517,159FederalNih-reporter · indexed 6 hours agoShare
Deciphering the role of HLA-F and KIR3DS1 on NK function and HIV pathogenesisNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionDCResponse due—Value$781,999FederalNih-reporter · indexed 6 hours agoShare
Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney CollaboratoryNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionMDResponse due—Value$5,433,689FederalNih-reporter · indexed 6 hours agoShare
Discovery of novel antivirulence drug targets in C. difficile by systematically demystifying its genetic network controlling toxin biosynthesisNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionTXResponse due—Value$165,234FederalpharmacyNih-reporter · indexed 6 hours agoShare
Leveraging the sensitivity of antigen-specific T cells to interrogate disease mechanisms and identify therapeutic targets for Long COVIDNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$175,428FederalNih-reporter · indexed 6 hours agoShare
Mechanistic characterization and rational design of Lassa virus entry inhibitorsNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionMAResponse due—Value$282,250FederalNih-reporter · indexed 6 hours agoShare
Fate-Mapping and Genetic Dissection of B-to-T Feedback Circuits Shaping Germinal-Center SelectionNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionNYResponse due—Value$210,000FederalNih-reporter · indexed 6 hours agoShare
Classical dendritic cells (cDC1) govern cardiac allograft toleranceNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionMOResponse due—Value$40,249FederalNih-reporter · indexed 6 hours agoShare
Type I interferon Impacts Treatment Response in Rheumatoid ArthritisNewclinicalGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionNYResponse due—Value$197,640FederalNih-reporter · indexed 6 hours agoShare
Human antibodies as broad alphavirus immunotherapeuticsNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionNYResponse due—Value$812,078FederalNih-reporter · indexed 6 hours agoShare
Estimating the Epidemiologic Impact of TB Vaccines using Mathematical ModelsNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionGAResponse due—Value$131,081FederalNih-reporter · indexed 6 hours agoShare
UCLA Rapid, Rigorous, Relevant Implementation Science Hub: Leveraging Implementation Science to End the HIV EpidemicNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionCAResponse due—Value$719,358FederalNih-reporter · indexed 6 hours agoShare
Mechanistic insights into the kinetics of Fc receptor-mediated placental antibody transfer to optimize maternal vaccine strategiesNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionVAResponse due—Value$470,417FederalNih-reporter · indexed 6 hours agoShare
A New Model for Valley Fever: Comparative Volatilomics of Coccidioides InfectionNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionAZResponse due—Value$78,500FederalNih-reporter · indexed 6 hours agoShare
Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptorsNewadministrativeGrantRecompeteBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionCAResponse due—Value$587,872FederalNih-reporter · indexed 6 hours agoShare
Novel In-Clinic Molecular Adjuvant Enhances Antiviral Humoral Immunity of Vaccines Across SexesNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionPAResponse due—Value$234,370FederalNih-reporter · indexed 6 hours agoShare
CHIPP-PrEP: Cabotegravir- Hormone Interrogation of Pharmacokinetics-Pharmacodynamics for HIV PreventionNewadministrativeGrantBuyerNational Institute of Allergy and Infectious DiseasesJurisdictionMDResponse due—Value$599,708FederalNih-reporter · indexed 6 hours agoShare